C-peptide analog (Diabetology)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameC-peptide analog (Diabetology)
Drug Alias Nameoral C-Peptide analog
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJersey
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiabetology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiabetology Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A